High Pancreatic n-3 Fatty Acids Prevent STZ-Induced Diabetes in Fat-1 Mice: Inflammatory Pathway Inhibition

DSpace/Manakin Repository

High Pancreatic n-3 Fatty Acids Prevent STZ-Induced Diabetes in Fat-1 Mice: Inflammatory Pathway Inhibition

Citable link to this page

 

 
Title: High Pancreatic n-3 Fatty Acids Prevent STZ-Induced Diabetes in Fat-1 Mice: Inflammatory Pathway Inhibition
Author: Bellenger, Jérôme; Bellenger, Sandrine; Bataille, Amandine; Nicolaou, Anna; Rialland, Mickaël; Tessier, Christian; Narce, Michel; Massey, Karen A.; Kang, Jing Xuan

Note: Order does not necessarily reflect citation order of authors.

Citation: Bellenger, Jérôme, Sandrine Bellenger, Amandine Bataille, Karen A. Massey, Anna Nicolaou, Mickaël Rialland, Christian Tessier, Jing X. Kang, and Michel Narce. 2011. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: Inflammatory pathway inhibition. Diabetes 60(4): 1090-1099.
Full Text & Related Files:
Abstract: Obejctive: Because of confounding factors, the effects of dietary n-3 polyunsaturated fatty acids (PUFA) on type 1 diabetes remain to be clarified. We therefore evaluated whether fat-1 transgenic mice, a well-controlled experimental model endogenously synthesizing n-3 PUFA, were protected against streptozotocin (STZ)-induced diabetes. We then aimed to elucidate the in vivo response at the pancreatic level. Research Design and Methods: \(\beta\)-Cell destruction was produced by multiple low-doses STZ (MLD-STZ). Blood glucose level, plasma insulin level, and plasma lipid analysis were then performed. Pancreatic mRNA expression of cytokines, the monocyte chemoattractant protein, and GLUT2 were evaluated as well as pancreas nuclear factor (NF)-\(\kappa\)B p65 and inhibitor of \(\kappa\)B (I\(\kappa\)B) protein expression. Insulin and cleaved caspase-3 immunostaining and lipidomic analysis were performed in the pancreas. Results: STZ-induced fat-1 mice did not develop hyperglycemia compared with wild-type mice, and \(\beta\)-cell destruction was prevented as evidenced by lack of histological pancreatic damage or reduced insulin level. The prevention of \(\beta\)-cell destruction was associated with no proinflammatory cytokine induction (tumor necrosis factor-\(\alpha\), interleukin-1\(\beta\), inducible nitric oxide synthase) in the pancreas, a decreased NF-\(\kappa\)B, and increased I\(\kappa\)B pancreatic protein expression. In the fat-1–treated mice, proinflammatory arachidonic-derived mediators as prostaglandin E\(_2\) and 12-hydroxyeicosatetraenoic acid were decreased and the anti-inflammatory lipoxin A\(_4\) was detected. Moreover, the 18-hydroxyeicosapentaenoic acid, precursor of the anti-inflammatory resolvin E1, was highly increased. Conclusions: Collectively, these findings indicate that fat-1 mice were protected against MLD-STZ–induced diabetes and pointed out for the first time in vivo the beneficial effects of n-3 PUFA at the pancreatic level, on each step of the development of the pathology—inflammation, \(\beta\)-cell damage—through cytokine response and lipid mediator production.
Published Version: doi:10.2337/db10-0901
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064083/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10336909
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters